HDR Gateway logo
HDR Gateway logo

Bookmarks

CCU002: SARS-CoV-2 infection and vaccination and the risk of vascular events

Safe People

Organisation name

University of Edinburgh

Organisation sector

Academic Institute

Applicant name(s)

William Whiteley

Sub-licence arrangements (if any)?

No

Safe Projects

Project ID

CCU002

Lay summary

Coronavirus infection (‘COVID-19’) might increase a person’s chance of having a stroke, heart attack or clot in the deep veins or lungs (‘blood vessel diseases’). During the COVID-19 pandemic, some doctors have looked after patients with COVID-19 who also had unusual strokes, clots or heart complaints. This suggests there could be a link between COVID-19 and blood vessel diseases. But no individual doctor will see enough patients to find out if COVID-19 really does increase the risk of blood vessel diseases. To understand more, we will use healthcare records to study every person alive in England, Scotland and Wales at the beginning of the pandemic in 2020. We will find out how many people had a stroke, heart attack, heart condition or other disease of the blood vessels over the following year. We will compare the number of people with COVID-19 infection who developed a blood vessel disease with the number of people without COVID-19 infection who developed a blood vessel disease. Different types of people might have different risks, so we will also examine people of different ages, ethnicities and medical history.

Public benefit statement

The result of this research will be an estimate of how much COVID-19 increases the risk of different blood vessel diseases. This information is needed so that people with COVID-19 know whether they need to worry about blood vessel diseases as they recover. If this research shows there is an increased risk, then treatments might be needed to reduce this. Following an urgent request from the MHRA and Chief Medical Officer, the analyses for this project will also address the urgent question of whether there is an association between the SARS-CoV-2 vaccine and vascular events , including very rare blood clotting events and myocarditis/pericarditis.

Latest approval date

30/10/2020

Safe Data

Dataset(s) name
Data sensitivity level

De-Personalised

Safe Setting

Access type

TRE